Results 81 to 90 of about 73,182 (252)

Homing exosomes following natural Blueprint for targeted drug delivery

open access: yesBMEMat, EarlyView.
Parental‐derived exosomes offer excellent homing, biocompatibility, and low immunogenicity. Various substances, such as chemical drugs, regulatory nucleic acids, and specific proteins, can be loaded into these exosomes for precise delivery. Then, exosomes specifically transfer the carried substances to their origin cells for targeted therapy ...
Mingliang Zhu   +4 more
wiley   +1 more source

Efficacy and Safety of Durvalumab and Tremelimumab in Metastatic Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesChronic Diseases and Translational Medicine, EarlyView.
PRISMA 2020 flow diagram of included studies. ABSTRACT Purpose Immune checkpoint inhibitors have transformed treatment strategies for metastatic non‐small cell lung cancer (mNSCLC). This study aimed to assess the efficacy and safety of durvalumab combined with tremelimumab compared with those of standard chemotherapy, particularly in patients with low ...
Ikhwan Rinaldi   +2 more
wiley   +1 more source

Case Study of a Cross‐Platform Evaluation of an Optimized Multicolor Flow Cytometry Immunophenotyping Assay for Human Peripheral Whole Blood

open access: yesCytometry Part A, EarlyView.
ABSTRACT Flow cytometry is a commonly used single‐cell analysis technique that can be applied for the immunophenotyping of human blood samples. Nowadays, increasing numbers of clinical trials include translational research programs utilizing flow‐based immune monitoring assays to assess patients' longitudinal immune status.
Lia Mogge   +4 more
wiley   +1 more source

Biochemical analysis of CTLA-4 immunoreactive material from human blood

open access: yesBMC Immunology, 2009
Background CTLA-4 was initially described as a membrane-bound molecule that inhibited lymphocyte activation by interacting with B7.1 and B7.2 molecules on antigen presenting cells.
Dennert Kate   +4 more
doaj   +1 more source

Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4) Polymorphism, Cancer, and Autoimmune Diseases

open access: yesAIMS Medical Science, 2017
Immune system dysfunction is one of the key features in onset and development of cancer and autoimmunity. Cytotoxic T-lymphocyte-antigen-4 (CTLA-4), as a leader immune checkpoint plays a crucial effects in the regulation of immune suppression and tolerance.
Maryam Tanhapour   +4 more
openaire   +2 more sources

Incidence and Predictors of Immune‐Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real‐World Cohort Study

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Immune checkpoint inhibitors (ICIs) frequently cause thyroid immune‐related adverse events (irAEs). Permanent hypothyroidism, the clinically most relevant phenotype, requires lifelong hormone replacement. We investigated its incidence, course, risk factors, and prognostic relevance under pembrolizumab.
Freya Koffka   +9 more
wiley   +1 more source

CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis

open access: yesScientific Reports
Uveitis is a leading cause of blindness in the world and autoimmune uveitis is an ocular tissue specific autoimmune disease. Utilizing experimental autoimmune uveitis (EAU), we can interrogate different immune responses in the mouse that are relevant to ...
Minjun Ahn   +3 more
doaj   +1 more source

Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) +49A>G (rs231775) gene polymorphism is not associated with COVID-19 severity and mortality in an Iranian population

open access: yesHeliyon
Introduction: Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates T cell immune responses as an immune activation inhibitor. Literature reviews suggest that COVID-19 is associated with dysregulation of the inflammatory immune response.
Ensie Sadat Mirsharif   +4 more
doaj   +1 more source

Heparanase‐Expressing Regulatory T Cells Drive Immunotherapy Resistance and Poor Outcomes in Lung Cancer

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Heparan sulfate proteoglycans (HSPGs) and their degrading enzyme heparanase (Hpse) play pivotal roles in tumor invasion and metastasis. Previous studies have reported associations between Hpse expression in tumor cells and patient prognosis. Although immune checkpoint inhibitors (ICIs) are a cornerstone of solid tumor therapy, the role of Hpse
Ryohiko Ozaki   +15 more
wiley   +1 more source

Cysteine Peptidases in Antitumor Immunity: Unraveling Antigen‐Presenting Cell Regulation and Therapeutic Potential

open access: yesiMetaMed, EarlyView.
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy